Reading guide
How we handle reported doses and cycles
Numbers can identify a claim without becoming a recommendation.
Editorial draft; scientific and translation review pending.
Keep the source attached
When a number is necessary for source comparison, record the author, edition, PDF page, molecule, route, unit, denominator and context. A daily amount, a per-application amount and the total mass of a vial are not interchangeable. Unknown fields remain unknown. Repetition across books does not establish independent confirmation.
A conflict is not an invitation to calculate
The audit found contradictory summaries and apparent unit errors in practitioner sources. Do not repair them by guessing mg versus micrograms or selecting a familiar dose. Identify the original page and seek a publisher correction. The public comparison omits unresolved administration numbers while retaining the fact and location of the error.
Evidence must match the regimen
A hormone-response experiment, an animal mg/kg dose or a topical trial does not validate an injected community cycle. No dose calculator, automatic titration plan or “optimal stack” recommendation is derived from these reports. Later observational records would document exposures chosen independently, without assigning them.
Source-reported quantity examples
Three paraphrased claims from one source, each with its limitation. They are not recommendations, optimal ranges or regimens, and are distinct from the synthetic research demo.
NOT A RECOMMENDATION.Each amount is attributed to the source identified for that entry: regulatory product labeling, human research, or community and practice sources. These source categories have different evidentiary roles. They are not medical advice, not a protocol, not a recommended or safe dose, and not evidence that it works. Do not use them to start, change or stop any treatment. Talk to a qualified healthcare professional.
| Profile | Reported quantity (EN / ES) | Interpretive limitation | Source and references |
|---|---|---|---|
| BPC-157 | Reported by Péptidos en la práctica — Volumen 2 (supplied edition; publication metadata not established) 500 micrograms/day in an early injury phase; the same source later describes 250 micrograms/day. 500 microgramos/día en una fase inicial de lesión; la misma fuente describe después 250 microgramos/día. | These are author-reported quantities, not a clinical comparison or a course-recommended range. The source also changes other interventions across phases. | Péptidos en la práctica — Volumen 2 (supplied edition; publication metadata not established) PDF page 13 · claim C006 |
| MOTS-c | Reported by Péptidos en la práctica — Volumen 2 (supplied edition; publication metadata not established) The source labels 5 mg as a minimum dose. La fuente rotula 5 mg como dosis mínima. | A label in a practitioner guide does not establish a validated human minimum, safe dose or effective regimen. Experimental and endogenous evidence cannot supply that validation. | Péptidos en la práctica — Volumen 2 (supplied edition; publication metadata not established) PDF page 31 · claim C018 |
| KPV | Reported by Péptidos en la práctica — Volumen 2 (supplied edition; publication metadata not established) The source gives 150–750 micrograms/day while discussing oral or subcutaneous use. La fuente da 150–750 microgramos/día al discutir uso oral o subcutáneo. | Combining routes in a source table does not establish equivalence. The audited preclinical evidence and FDA review do not validate that human schedule. | Péptidos en la práctica — Volumen 2 (supplied edition; publication metadata not established) PDF page 40 · claim C026 |
NOT A RECOMMENDATION.Each amount is attributed to the source identified for that entry: regulatory product labeling, human research, or community and practice sources. These source categories have different evidentiary roles. They are not medical advice, not a protocol, not a recommended or safe dose, and not evidence that it works. Do not use them to start, change or stop any treatment. Talk to a qualified healthcare professional.
Profiles drawing on these sources
References
- 1.
- 2.
- 3.
